Back to Journals » Lung Cancer: Targets and Therapy » Volume 15

Commentary

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

       
Total article views   HTML views PDF downloads Totals
1,012 Dovepress* 1,012+ 18 1,030
Totals 1,012 18 1,030
*Since 12 April 2024

View citations on PubMed Central and Google Scholar